SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-21-094507
Filing Date
2021-03-25
Accepted
2021-03-25 16:33:05
Documents
9
Period of Report
2021-05-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A d106749dpre14a.htm PRE 14A 627764
2 GRAPHIC g106749g01k50.jpg GRAPHIC 40419
3 GRAPHIC g106749g23k68.jpg GRAPHIC 26481
4 GRAPHIC g106749g25m69.jpg GRAPHIC 106124
5 GRAPHIC g106749g53d28.jpg GRAPHIC 44917
6 GRAPHIC g106749g55j41.jpg GRAPHIC 105040
7 GRAPHIC g106749g64n91.jpg GRAPHIC 46696
8 GRAPHIC g106749snap20.jpg GRAPHIC 253553
9 GRAPHIC g106749snap6.jpg GRAPHIC 575598
  Complete submission text file 0001193125-21-094507.txt   2280982
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33038 | Film No.: 21772823
SIC: 2834 Pharmaceutical Preparations